People choose GLP-1 (glucagon-like peptide-1) receptor agonists for weight loss due to several compelling reasons. These medications, originally developed for managing type 2 diabetes, have been shown to aid in weight loss by impacting various mechanisms in the body. Here are some key reasons:
GLP-1 receptor agonists, such as semaglutide and liraglutide, work by stimulating GLP-1 receptors in the brain, particularly in areas that regulate appetite. This leads to reduced hunger, cravings, and lower overall food intake, helping individuals to consume fewer calories.
These medications slow the rate at which food moves through the stomach, making individuals feel full longer. This extended feeling of satiety helps in controlling portion sizes and reducing overeating.
GLP-1 agonists improve insulin sensitivity and regulate blood sugar levels, which can help reduce fat storage. Stabilized blood sugar levels may also prevent energy crashes that lead to overeating or cravings for high-sugar foods.
Many people are drawn to GLP-1 medications because they have been scientifically proven to promote significant weight loss in clinical trials. For example, semaglutide (sold under the brand name Wegovy) has shown an average weight loss of 10-15% of body weight in patients using the drug over a period of months.
Compared to bariatric surgery or more drastic interventions, GLP-1 agonists are a less invasive method of weight loss. They are typically administered via injection once daily or weekly, depending on the specific drug.
Beyond helping people lose weight, GLP-1 medications have been shown to assist in maintaining weight loss over time. This is particularly appealing for those who have struggled with yo-yo dieting or regaining weight after other weight loss efforts.
For people with type 2 diabetes, GLP-1 drugs offer the dual advantage of better blood sugar control and weight loss. This makes them an attractive option for individuals seeking to manage both conditions simultaneously.
Some individuals prefer GLP-1 receptor agonists because traditional weight loss medications can have undesirable side effects, such as jitteriness, insomnia, or increased heart rate. GLP-1 agonists are often perceived as safer and better tolerated.
However, it’s important to note that GLP-1 medications can have side effects, including nausea, vomiting, and gastrointestinal discomfort, and they require a prescription. Therefore, they are often used under the guidance of a healthcare professional, especially for individuals with specific health conditions.
For your weight loss needs in Hackensack, Bergen County, New Jersey please contact Dr. Anjana Chhabra at Institute for Weight Management.
150 Overlook Ave,
Hackensack, NJ 07601
Monday
Closed
Tuesday
9:00 am - 3:00 pm
Wednesday
9:00 am - 3:00 pm
Thursday
12:00 pm - 7:00 pm
Friday
Closed
Saturday
9:00 am - 1:00 pm
Every Other Saturday
Sunday
Closed